AstraZeneca hits back at media reports on efficacy of COVID-19 vaccine

The company says reports that vaccine has a less than 10% efficacy in those over 65 are 'incorrect'

AstraZeneca has dismissed claims that its COVID-19 vaccine is not effective for people over 65.

German daily papers Handelsblatt and Bild both reported on 25 January the vaccine co-developed by AstraZeneca and the University of Oxford had an efficacy of less than 10% in patients over 65.